Clinical Trial Update: Study of HBV Therapeutic Vaccines GS-2829 and GS-6779 in Healthy Participants and Participants With Chronic Hepatitis B [Phase 1]

View source ↗

Summary

Phase 1 clinical trial evaluating the HBV therapeutic vaccines GS-2829 and GS-6779 in healthy participants and individuals with Chronic Hepatitis B has complete…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Hepatitis B

Drugs mentioned

• GS-2829
• GS-6779

Snippet

Sponsor: Gilead Sciences | Conditions: Chronic Hepatitis B | Phase 1 | Status: COMPLETED | Results posted: 2026-01-23